Assessment of inter-rater reliability of clinical hidradenitis suppurativa outcome measures using ultrasonography.

Autor: Lyons AB; Multicultural Center, Department of Dermatology, Henry Ford Health System, Detroit, MI, USA., Narla S; Department of Dermatology, St Lukes Hospital, Easton, PA, USA., Kohli I; Multicultural Center, Department of Dermatology, Henry Ford Health System, Detroit, MI, USA.; Department of Physics and Astronomy, Wayne State University, Detroit, MI, USA., Zubair R; Department of Dermatology, Broward Hospital, Ft Lauderdale, FL, USA., Nahhas AF; Department of Dermatology, Beaumont Health-Farmington Hills, Farmington Hills, MI, USA., Braunberger TL; Multicultural Center, Department of Dermatology, Henry Ford Health System, Detroit, MI, USA., Joseph MK; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA., Nicholson CL; Department of Dermatology, Wayne State University, Detroit, MI, USA., Jacobsen G; Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, USA., Hamzavi IH; Multicultural Center, Department of Dermatology, Henry Ford Health System, Detroit, MI, USA.
Jazyk: angličtina
Zdroj: Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Feb; Vol. 47 (2), pp. 319-324. Date of Electronic Publication: 2021 Oct 10.
DOI: 10.1111/ced.14889
Abstrakt: Background: Hidradenitis suppurativa (HS) staging and severity is typically based upon physical examination findings, which can result in misclassification of severity based on subclinical disease activity and significant variation between healthcare providers. Ultrasonography (US) is an objective tool to help evaluate subclinical disease and to more accurately classify disease severity.
Aim: To evaluate inter-rater reliability in HS disease severity assessment using clinical and US techniques.
Methods: In total, 20 subjects underwent clinical evaluation of HS, independently by two physicians, using clinical outcome measures, including Hurley, Sartorius, HS Physician Global Assessment (HS-PGA) and Hidradenitis Suppurativa Clinical Response (HiSCR). US was subsequently performed, and clinical assessments were repeated. Intraclass correlation coefficients (ICC) were obtained to evaluate inter-rater agreement of each outcome measure before and after US.
Results: Pre-US to post-US improvement in ICC was seen with the Sartorius, HiSCR nodule and abscess count, and the HiSCR draining fistula count. The scores went from having 'good' rater agreement for Sartorius and HiSCR nodule and abscess count, to 'poor' rater agreement for HiSCR draining fistula count, to 'excellent' rater agreement among these scores.
Conclusion: US improved inter-rater agreement and should be used in conjunction with physical examination findings to evaluate disease severity to ensure uniform staging of HS.
(© 2021 British Association of Dermatologists.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje